Hepatitis C antibody intraassay correlation: Is retest in duplicate necessary?

Transfusion

Volumn 47, Issue 9, 2007, Pages 1686-1690

  Contreras, Ana M ^a   Tinoco, Erendi ^b   Celis, Alfredo ^b   Novelo, Bárbara ^b   Romero, M V Patricia ^b   Carrada, Etelvina ^b   Jiménez Méndez, Ricardo ^b   Morales, Avelino Bernal ^b   García, Irais Olivares ^b   Rodríguez Carbajal, Otilia ^b   Hernández Lugo, María I ^b   Olivares, Laura P ^b   González, Claudia Rebolledo ^b   Hernández, Sara Ruelas ^b   Mercado Suárez, Miguel F ^b   Martínez Perry, Samuel ^b   Herrera Aguilar, Jorge ^b   Amatón, Rene ^b   López Arroyo, José Luis ^b   Aguirre Aguirre, Ignacio J ^b   García Ramos, Víctor Hugo ^b   González Santos, Mario A ^b   Juárez Terrazas, Jorge L ^b   Gutiérrez Almanza, Javier ^b   Rivas, Martha Venegas ^b   Herrera, Guadalupe Contreras ^b   Del Río, Luz Teresa Velarde ^b   Miranda, José Roberto ^b   Vargas Maldonado, Tomás M ^b   Mariscal, Cecilia Guillen ^b   Malagon, Araceli ^b   Del Carmen Mavil Lara, Luz ^b   Barbosa, Rita ^b   De Jesús Pichardo, María ^b   De Lourdes Pandura, Rosa ^b   Palomares, Benny ^b   Chongo Alfaro, Martha L ^b   more..

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ALGORITHM; ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD SAMPLING; CHEMOLUMINESCENCE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EVALUATION; HEPATITIS C; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MICROPARTICLE ENZYME IMMUNOASSAY; SCREENING;

HEPACIVIRUS; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOASSAY; REPRODUCIBILITY OF RESULTS; RNA, VIRAL;

EID: 34548126927     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01342.x     Document Type: Article

References (11)

1. Tobler LH, Tegtmeier G, Stramer SL, et al. Lookback on donors who are repeatedly reactive on first-generation hepatitis C virus assays: justification and rational implementation. Transfusion 2000 40 : 15 24.
2. Alter MJ, Kuhnert WL, Finelli L Centers for Disease Control and Prevention. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003 52 (RR-3 1 15.
3. Armstrong BK, White E, Saracci R. Principles of exposure measurement in epidemiology. Oxford : Oxford University Press 1992. p. 8 1 2.
4. Hepatitis C virus encoded antigen (recombinant HCr43, c200, c100-3, and NS5) Abbott AxSYM Anti-HCV 3.0 [package insert]. Abbott Park (IL) : Abbott Laboratories 2004.
5. Hepatitis C virus encoded antigen (recombinant c22-3, c200, and NS5) Ortho VITROS Anti-HCV 3.0 [package insert]. Ortho Raritan (NJ) : Ortho-Clinical Diagnostics, Johnson and Johnson Company 2003.
6. Hepatitis C virus encoded antigen (recombinant c100-3, HCr43, and NS5) Abbott PRISM HCV 3.0 [package insert]. Abbott Park (IL) : Abbott Laboratories 2002.
7. Dufour DR, Talastas M, Fernandez MD, Harris B, Strader DB, Seeff LB. Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection. Clin Chem 2003 49 : 479 86.
8. Tobler LH, Stramer SL, Lee SR, et al. Impact of HCV 3.0 relative to HCV 2.0 EIA on blood-donor screening. Transfusion 2003 43 : 1452 9.
9. Courouce AM, Bouchardeau F, Girault A, Le Marrec N. Significance of NS3 and NS5 antigens in screening for HCV antibody. Lancet 1994 343 : 853 4.
10. Goffin E, Pirson Y, Cornu C, et al. Significance of NS3 and NS5 antigens in screening for HCV antibody. Lancet 1994 343 : 854.
11. 2005 annual report [monograph on the Internet]. Abbott Park (IL) : Abbott Laboratories [accessed 2007 May 22]. Available from: http://www.abbott.com/ static/content/microsite/annual_report/2005/includes/abbott_ar05_full.pdf